{"transactions":[{"id":828349,"issuer":{"id":4602,"kind":"organization","name":"Damora Therapeutics, Inc.","symbol":"DMRA"},"owners":[{"id":56087,"kind":"person","name":"Bruno Julianne","position":1,"cik":"0002019645","reported_name":"Bruno Julianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-25T17:57:22.000Z","date":"2026-03-23","kind":"grant","planned":false,"acquired":true,"shares":37313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase shares of common stock of the Issuer. This option will vest in equal monthly installments through March 23, 2029, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":37313,"derivative":{"exercise_price":23.05,"expiration_date":"2036-03-23","underlying":"Common Stock","underlying_shares":37313},"source":{"system":"sec-edgar","filing":"0001193125-26-124455","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019645/000119312526124455/ownership.xml","form_type":"4"}},{"id":907852,"issuer":{"id":4602,"kind":"organization","name":"Damora Therapeutics, Inc.","symbol":"DMRA"},"owners":[{"id":56087,"kind":"person","name":"Bruno Julianne","position":1,"cik":"0002019645","reported_name":"Bruno Julianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2026-02-12T06:05:08.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":false,"shares":129,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Following receipt of the Requisite Stockholder Approval, each share of Series C Preferred Stock automatically converted into 1,000 shares of Common Stock, subject to certain beneficial ownership limitations. The Series C Preferred Stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 9, 2026, the Issuer's stockholders approved the issuance of Common Stock upon conversion of the Issuer's Series C Non-Voting Convertible Preferred Stock, par value $0.00001 per share (\"Series C Preferred Stock\") (the \"Requisite Stockholder Approval\"). Accordingly, pursuant to the terms of the Certificate of Designations of Preferences, Rights and Limitations of Series C Non-Voting Convertible Preferred Stock, 129 shares of Series C Preferred Stock held by the Reporting Person were converted into 129,000 shares of Common Stock. The securities of the Issuer held by the Reporting Person, including the shares of Common Stock received upon conversion of the Series C Preferred Stock, are subject to the terms a lock-up agreement entered into with the underwriters for the Issuer's public offering, pursuant to which the Reporting Person agreed, subject to certain exceptions, not to directly or indirectly sell or otherwise transfer securities of the Issuer for a period of 60 days"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) following the date of the final prospectus supplement relating to the public offering, which was February 10, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Following receipt of the Requisite Stockholder Approval, each share of Series C Preferred Stock automatically converted into 1,000 shares of Common Stock, subject to certain beneficial ownership limitations. The Series C Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Following receipt of the Requisite Stockholder Approval, each share of Series C Preferred Stock automatically converted into 1,000 shares of Common Stock, subject to certain beneficial ownership limitations. The Series C Preferred Stock has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":129000},"source":{"system":"sec-edgar","filing":"0001193125-26-047537","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2019645/000119312526047537/ownership.xml","form_type":"4"}},{"id":907851,"issuer":{"id":4602,"kind":"organization","name":"Damora Therapeutics, Inc.","symbol":"DMRA"},"owners":[{"id":56087,"kind":"person","name":"Bruno Julianne","position":1,"cik":"0002019645","reported_name":"Bruno Julianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-12T06:05:08.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":true,"shares":129000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 9, 2026, the Issuer's stockholders approved the issuance of Common Stock upon conversion of the Issuer's Series C Non-Voting Convertible Preferred Stock, par value $0.00001 per share (\"Series C Preferred Stock\") (the \"Requisite Stockholder Approval\"). Accordingly, pursuant to the terms of the Certificate of Designations of Preferences, Rights and Limitations of Series C Non-Voting Convertible Preferred Stock, 129 shares of Series C Preferred Stock held by the Reporting Person were converted into 129,000 shares of Common Stock. The securities of the Issuer held by the Reporting Person, including the shares of Common Stock received upon conversion of the Series C Preferred Stock, are subject to the terms a lock-up agreement entered into with the underwriters for the Issuer's public offering, pursuant to which the Reporting Person agreed, subject to certain exceptions, not to directly or indirectly sell or otherwise transfer securities of the Issuer for a period of 60 days"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) following the date of the final prospectus supplement relating to the public offering, which was February 10, 2026."}],"balance_after":137032,"source":{"system":"sec-edgar","filing":"0001193125-26-047537","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019645/000119312526047537/ownership.xml","form_type":"4"}},{"id":1193753,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":56087,"kind":"person","name":"Bruno Julianne","position":1,"cik":"0002019645","reported_name":"Bruno Julianne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-24T17:35:07.000Z","date":"2025-03-20","kind":"exercise","planned":false,"acquired":false,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 15,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 15,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."}],"balance_after":11250,"derivative":{"underlying":"Common Shares","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0000950170-25-043974","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2019645/000095017025043974/ownership.xml","form_type":"4"}},{"id":1193752,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":56087,"kind":"person","name":"Bruno Julianne","position":1,"cik":"0002019645","reported_name":"Bruno Julianne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2025-03-24T17:35:07.000Z","date":"2025-03-21","kind":"sale","planned":false,"acquired":false,"shares":1714,"price":41.23,"value":70668.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":10544,"source":{"system":"sec-edgar","filing":"0000950170-25-043974","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2019645/000095017025043974/ownership.xml","form_type":"4"}},{"id":1193751,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":56087,"kind":"person","name":"Bruno Julianne","position":1,"cik":"0002019645","reported_name":"Bruno Julianne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2025-03-24T17:35:07.000Z","date":"2025-03-20","kind":"exercise","planned":false,"acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":12258,"source":{"system":"sec-edgar","filing":"0000950170-25-043974","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019645/000095017025043974/ownership.xml","form_type":"4"}},{"id":1200630,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":56087,"kind":"person","name":"Bruno Julianne","position":1,"cik":"0002019645","reported_name":"Bruno Julianne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-18T17:35:05.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."}],"balance_after":27500,"derivative":{"underlying":"Common Shares","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0000950170-25-041468","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2019645/000095017025041468/ownership.xml","form_type":"4"}},{"id":1200629,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":56087,"kind":"person","name":"Bruno Julianne","position":1,"cik":"0002019645","reported_name":"Bruno Julianne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-18T17:35:05.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":36666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 14, 2025 with respect to 36,666 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 14, 2025."}],"balance_after":36666,"derivative":{"exercise_price":42.12,"expiration_date":"2035-03-14","underlying":"Common Shares","underlying_shares":36666},"source":{"system":"sec-edgar","filing":"0000950170-25-041468","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019645/000095017025041468/ownership.xml","form_type":"4"}},{"id":1210173,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":56087,"kind":"person","name":"Bruno Julianne","position":1,"cik":"0002019645","reported_name":"Bruno Julianne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-12T19:05:03.000Z","date":"2025-03-11","kind":"exercise","planned":false,"acquired":false,"shares":435,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit award was granted on March 11, 2021 with respect to 1,740 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit award was granted on March 11, 2021 with respect to 1,740 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":435},"source":{"system":"sec-edgar","filing":"0000950170-25-038214","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2019645/000095017025038214/ownership.xml","form_type":"4"}},{"id":1210172,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":56087,"kind":"person","name":"Bruno Julianne","position":1,"cik":"0002019645","reported_name":"Bruno Julianne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-12T19:05:03.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":2399,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on March 10, 2023 with respect to 9,593 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on March 10, 2023 with respect to 9,593 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027."}],"balance_after":4796,"derivative":{"underlying":"Common Shares","underlying_shares":2399},"source":{"system":"sec-edgar","filing":"0000950170-25-038214","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2019645/000095017025038214/ownership.xml","form_type":"4"}},{"id":1210171,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":56087,"kind":"person","name":"Bruno Julianne","position":1,"cik":"0002019645","reported_name":"Bruno Julianne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2025-03-12T19:05:03.000Z","date":"2025-03-12","kind":"sale","planned":false,"acquired":false,"shares":190,"price":43.32,"value":8230.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":8508,"source":{"system":"sec-edgar","filing":"0000950170-25-038214","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2019645/000095017025038214/ownership.xml","form_type":"4"}},{"id":1210170,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":56087,"kind":"person","name":"Bruno Julianne","position":1,"cik":"0002019645","reported_name":"Bruno Julianne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2025-03-12T19:05:03.000Z","date":"2025-03-11","kind":"exercise","planned":false,"acquired":true,"shares":435,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":8698,"source":{"system":"sec-edgar","filing":"0000950170-25-038214","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2019645/000095017025038214/ownership.xml","form_type":"4"}},{"id":1210169,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":56087,"kind":"person","name":"Bruno Julianne","position":1,"cik":"0002019645","reported_name":"Bruno Julianne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2025-03-12T19:05:03.000Z","date":"2025-03-11","kind":"sale","planned":false,"acquired":false,"shares":1198,"price":42.42,"value":50819.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":8263,"source":{"system":"sec-edgar","filing":"0000950170-25-038214","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2019645/000095017025038214/ownership.xml","form_type":"4"}},{"id":1210168,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":56087,"kind":"person","name":"Bruno Julianne","position":1,"cik":"0002019645","reported_name":"Bruno Julianne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2025-03-12T19:05:03.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":2399,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":9461,"source":{"system":"sec-edgar","filing":"0000950170-25-038214","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019645/000095017025038214/ownership.xml","form_type":"4"}},{"id":1260697,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":56087,"kind":"person","name":"Bruno Julianne","position":1,"cik":"0002019645","reported_name":"Bruno Julianne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-19T17:35:05.000Z","date":"2025-02-18","kind":"exercise","planned":false,"acquired":false,"shares":650,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 2,600 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 2,600 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."}],"balance_after":650,"derivative":{"underlying":"Common Shares","underlying_shares":650},"source":{"system":"sec-edgar","filing":"0000950170-25-023387","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2019645/000095017025023387/ownership.xml","form_type":"4"}},{"id":1260696,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":56087,"kind":"person","name":"Bruno Julianne","position":1,"cik":"0002019645","reported_name":"Bruno Julianne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2025-02-19T17:35:05.000Z","date":"2025-02-19","kind":"sale","planned":false,"acquired":false,"shares":333,"price":52.8,"value":17582.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":7062,"source":{"system":"sec-edgar","filing":"0000950170-25-023387","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2019645/000095017025023387/ownership.xml","form_type":"4"}},{"id":1260695,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":56087,"kind":"person","name":"Bruno Julianne","position":1,"cik":"0002019645","reported_name":"Bruno Julianne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2025-02-19T17:35:05.000Z","date":"2025-02-18","kind":"exercise","planned":false,"acquired":true,"shares":650,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":7395,"source":{"system":"sec-edgar","filing":"0000950170-25-023387","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019645/000095017025023387/ownership.xml","form_type":"4"}},{"id":1384251,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":56087,"kind":"person","name":"Bruno Julianne","position":1,"cik":"0002019645","reported_name":"Bruno Julianne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-18T17:35:06.000Z","date":"2024-10-16","kind":"grant","planned":false,"acquired":true,"shares":18333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on October 16, 2024 with respect to 18,333 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 16, 2024."}],"balance_after":18333,"derivative":{"exercise_price":49,"expiration_date":"2034-10-16","underlying":"Common Shares","underlying_shares":18333},"source":{"system":"sec-edgar","filing":"0000950170-24-115695","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019645/000095017024115695/ownership.xml","form_type":"4"}},{"id":1470976,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":56087,"kind":"person","name":"Bruno Julianne","position":1,"cik":"0002019645","reported_name":"Bruno Julianne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2024-06-24T17:35:03.000Z","date":"2024-06-20","kind":"exercise","planned":false,"acquired":false,"shares":7000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on December 14, 2021 with respect to 7,000 Common Shares, with 100% of the shares vesting on June 20, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on December 14, 2021 with respect to 7,000 Common Shares, with 100% of the shares vesting on June 20, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0000950170-24-076916","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2019645/000095017024076916/ownership.xml","form_type":"4"}},{"id":1470975,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":56087,"kind":"person","name":"Bruno Julianne","position":1,"cik":"0002019645","reported_name":"Bruno Julianne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2024-06-24T17:35:03.000Z","date":"2024-06-21","kind":"sale","planned":false,"acquired":false,"shares":3366,"price":56.09,"value":188798.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":6745,"source":{"system":"sec-edgar","filing":"0000950170-24-076916","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2019645/000095017024076916/ownership.xml","form_type":"4"}},{"id":1470974,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":56087,"kind":"person","name":"Bruno Julianne","position":1,"cik":"0002019645","reported_name":"Bruno Julianne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2024-06-24T17:35:03.000Z","date":"2024-06-20","kind":"exercise","planned":false,"acquired":true,"shares":7000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":10111,"source":{"system":"sec-edgar","filing":"0000950170-24-076916","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019645/000095017024076916/ownership.xml","form_type":"4"}},{"id":1502278,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":56087,"kind":"person","name":"Bruno Julianne","position":1,"cik":"0002019645","reported_name":"Bruno Julianne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2024-05-24T16:15:54.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This restricted stock unit award was granted on May 23, 2024 with respect to 20,000 Common Shares, with 100% of the shares vesting on  May 23, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This restricted stock unit award was granted on May 23, 2024 with respect to 20,000 Common Shares, with 100% of the shares vesting on  May 23, 2026."}],"balance_after":20000,"derivative":{"underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-24-064607","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019645/000095017024064607/ownership.xml","form_type":"4"}}]}